Beneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitope
about
Alterations in immunodominance of Streptococcus mutans AgI/II: lessons learned from immunomodulatory antibodiesThe changing faces of Streptococcus antigen I/II polypeptide family adhesins.An intramolecular lock facilitates folding and stabilizes the tertiary structure of Streptococcus mutans adhesin P1.Immunogenicity and in vitro and in vivo protective effects of antibodies targeting a recombinant form of the Streptococcus mutans P1 surface protein.A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune responseInduction of neutralizing antibodies in mice immunized with an amino-terminal polypeptide of Streptococcus mutans P1 protein produced by a recombinant Bacillus subtilis strain.Identification of a supramolecular functional architecture of Streptococcus mutans adhesin P1 on the bacterial cell surface.A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice.An intramolecular interaction involving the N terminus of a streptococcal adhesin affects its conformation and adhesive function.Immunogenicity and prediction of epitopic region of antigen Ag I/II and glucosyltransferase from Streptococcus mutans.Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines
P2860
Q30355763-B06F6902-2048-4CC7-8F03-1D215E8F4894Q34017500-8DCF5075-ACBD-4183-A6D8-DBC1A6086A35Q34480684-FB5701CE-B9E1-4E86-843E-F7EB257DAC2FQ34595783-1D8CEE80-FD11-4526-9361-0F17F7EE789EQ35165024-F69CE442-DC56-4109-873F-CA3E7A8A5160Q35206440-953B3685-01B0-48DB-8E01-AAEA3B5182E4Q35580825-711FF929-E99B-4D3F-A723-ABA58FAC0252Q35867546-E105C560-123C-41D9-8C2F-D33ED1E055FFQ36832691-E9106D09-4DDC-4D21-AC23-05EDB4A478D8Q40626034-B06AE942-0C6E-4624-A87A-0F84C92C4D40Q58707657-5E2A1E5A-9BE2-4B0E-84C9-AC276F1DCE7F
P2860
Beneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitope
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Beneficial immunomodulation by ...... e of a relevant target epitope
@ast
Beneficial immunomodulation by ...... e of a relevant target epitope
@en
type
label
Beneficial immunomodulation by ...... e of a relevant target epitope
@ast
Beneficial immunomodulation by ...... e of a relevant target epitope
@en
prefLabel
Beneficial immunomodulation by ...... e of a relevant target epitope
@ast
Beneficial immunomodulation by ...... e of a relevant target epitope
@en
P2093
P2860
P356
P1476
Beneficial immunomodulation by ...... e of a relevant target epitope
@en
P2093
L Jeannine Brady
Monika W Oli
Rebekah A Robinette
William P McArthur
P2860
P304
P356
10.4049/JIMMUNOL.0803300
P407
P577
2009-09-14T00:00:00Z